187 related articles for article (PubMed ID: 37882537)
1. Elevated 4R tau contributes to endolysosomal dysfunction and neurodegeneration in VCP-related frontotemporal dementia.
Hung C; Patani R
Brain; 2024 Mar; 147(3):970-979. PubMed ID: 37882537
[TBL] [Abstract][Full Text] [Related]
2. 4R tau drives endolysosomal and autophagy dysfunction in frontotemporal dementia.
Hung C; Patani R
Autophagy; 2024 Jan; ():1-2. PubMed ID: 38174587
[TBL] [Abstract][Full Text] [Related]
3. [Aberrant Interaction Between FUS and SFPQ in Neurons in a Wide Range of FTLD Spectrum Diseases].
Ishigaki S
Brain Nerve; 2021 Sep; 73(9):1021-1028. PubMed ID: 34462374
[TBL] [Abstract][Full Text] [Related]
4. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
5. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
6. Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report.
Kobayashi R; Naruse H; Kawakatsu S; Iseki C; Suzuki Y; Koyama S; Morioka D; Ishiura H; Mitsui J; Ohta Y; Tsuji S; Toda T; Otani K
BMC Neurol; 2022 Nov; 22(1):406. PubMed ID: 36329418
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
8. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Beckers J; Tharkeshwar AK; Van Damme P
Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
[TBL] [Abstract][Full Text] [Related]
9. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
[TBL] [Abstract][Full Text] [Related]
10. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS.
Luisier R; Tyzack GE; Hall CE; Mitchell JS; Devine H; Taha DM; Malik B; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Nat Commun; 2018 May; 9(1):2010. PubMed ID: 29789581
[TBL] [Abstract][Full Text] [Related]
11. Three VCP Mutations in Patients with Frontotemporal Dementia.
Wong TH; Pottier C; Hondius DC; Meeter LHH; van Rooij JGJ; Melhem S; ; van Minkelen R; van Duijn CM; Rozemuller AJM; Seelaar H; Rademakers R; van Swieten JC
J Alzheimers Dis; 2018; 65(4):1139-1146. PubMed ID: 30103325
[TBL] [Abstract][Full Text] [Related]
12. Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis.
Hogan AL; Grima N; Fifita JA; McCann EP; Heng B; Fat SCM; Wu S; Maharjan R; Cain AK; Henden L; Rayner S; Tarr I; Zhang KY; Zhao Q; Zhang ZH; Wright A; Lee A; Morsch M; Yang S; Williams KL; Blair IP
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):990-1003. PubMed ID: 34288034
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 and FUS mislocalization in VCP mutant motor neurons is reversed by pharmacological inhibition of the VCP D2 ATPase domain.
Harley J; Hagemann C; Serio A; Patani R
Brain Commun; 2021; 3(3):fcab166. PubMed ID: 34396115
[TBL] [Abstract][Full Text] [Related]
14. SVIP is a molecular determinant of lysosomal dynamic stability, neurodegeneration and lifespan.
Johnson AE; Orr BO; Fetter RD; Moughamian AJ; Primeaux LA; Geier EG; Yokoyama JS; Miller BL; Davis GW
Nat Commun; 2021 Jan; 12(1):513. PubMed ID: 33479240
[TBL] [Abstract][Full Text] [Related]
15. One family, one gene and three phenotypes: A novel VCP (valosin-containing protein) mutation associated with myopathy with rimmed vacuoles, amyotrophic lateral sclerosis and frontotemporal dementia.
Abrahao A; Abath Neto O; Kok F; Zanoteli E; Santos B; Pinto WB; Barsottini OG; Oliveira AS; Pedroso JL
J Neurol Sci; 2016 Sep; 368():352-8. PubMed ID: 27538664
[TBL] [Abstract][Full Text] [Related]
16. Modeling ALS and FTD with iPSC-derived neurons.
Lee S; Huang EJ
Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
[TBL] [Abstract][Full Text] [Related]
17. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
[TBL] [Abstract][Full Text] [Related]
18. Stress-Specific Spatiotemporal Responses of RNA-Binding Proteins in Human Stem-Cell-Derived Motor Neurons.
Harley J; Patani R
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172210
[TBL] [Abstract][Full Text] [Related]
19. MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.
Biswas MHU; Almeida S; Lopez-Gonzalez R; Mao W; Zhang Z; Karydas A; Geschwind MD; Biernat J; Mandelkow EM; Futai K; Miller BL; Gao FB
Stem Cell Reports; 2016 Sep; 7(3):316-324. PubMed ID: 27594586
[TBL] [Abstract][Full Text] [Related]
20. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
